Literature DB >> 26301337

Task-based evaluation of a 4D MAP-RBI-EM image reconstruction method for gated myocardial perfusion SPECT using a human observer study.

Taek-Soo Lee, Takahiro Higuchi, Riikka Lautamäki, Frank M Bengel, Benjamin M W Tsui.   

Abstract

We evaluated the performance of a new 4D image reconstruction method for improved 4D gated myocardial perfusion (MP) SPECT using a task-based human observer study. We used a realistic 4D NURBS-based Cardiac-Torso (NCAT) phantom that models cardiac beating motion. Half of the population was normal; the other half had a regional hypokinetic wall motion abnormality. Noise-free and noisy projection data with 16 gates/cardiac cycle were generated using an analytical projector that included the effects of attenuation, collimator-detector response, and scatter (ADS), and were reconstructed using the 3D FBP without and 3D OS-EM with ADS corrections followed by different cut-off frequencies of a 4D linear post-filter. A 4D iterative maximum a posteriori rescaled-block (MAP-RBI)-EM image reconstruction method with ADS corrections was also used to reconstruct the projection data using various values of the weighting factor for its prior. The trade-offs between bias and noise were represented by the normalized mean squared error (NMSE) and averaged normalized standard deviation (NSDav), respectively. They were used to select reasonable ranges of the reconstructed images for use in a human observer study. The observers were trained with the simulated cine images and were instructed to rate their confidence on the absence or presence of a motion defect on a continuous scale. We then applied receiver operating characteristic (ROC) analysis and used the area under the ROC curve (AUC) index. The results showed that significant differences in detection performance among the different NMSE-NSDav combinations were found and the optimal trade-off from optimized reconstruction parameters corresponded to a maximum AUC value. The 4D MAP-RBI-EM with ADS correction, which had the best trade-off among the tested reconstruction methods, also had the highest AUC value, resulting in significantly better human observer detection performance when detecting regional myocardial wall motion abnormality. We concluded that the NMSE-NSDav trade-off was shown to agree with observer performance for the detection task of the regional motion abnormality, and the optimized 4D MAP-RBI-EM method with ADS corrections provides significant improvement compared to 3D FBP and 3D OS-EM with ADS corrections in detecting regional myocardial wall motion abnormali in 4D gated MP SPECT.

Entities:  

Mesh:

Year:  2015        PMID: 26301337      PMCID: PMC4582998          DOI: 10.1088/0031-9155/60/17/6789

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  37 in total

1.  Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT: an early sign of cardiac involvement.

Authors:  K Nakajima; J Taki; M Kawano; T Higuchi; S Sato; C Nishijima; K Takehara; N Tonami
Journal:  J Nucl Med       Date:  2001-02       Impact factor: 10.057

2.  Effects of motion, attenuation, and scatter corrections on gated cardiac SPECT reconstruction.

Authors:  Xiaofeng Niu; Yongyi Yang; Mingwu Jin; Miles N Wernick; Michael A King
Journal:  Med Phys       Date:  2011-12       Impact factor: 4.071

Review 3.  Gated SPECT in assessment of regional and global left ventricular function: major tool of modern nuclear imaging.

Authors:  Aiden Abidov; Guido Germano; Rory Hachamovitch; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

4.  Fully 4D motion-compensated reconstruction of cardiac SPECT images.

Authors:  Erwan Gravier; Yongyi Yang; Michael A King; Mingwu Jin
Journal:  Phys Med Biol       Date:  2006-08-30       Impact factor: 3.609

5.  Block-iterative techniques for fast 4D reconstruction using a priori motion models in gated cardiac SPECT.

Authors:  D S Lalush; B M Tsui
Journal:  Phys Med Biol       Date:  1998-04       Impact factor: 3.609

6.  Determination of the optimum filter function for SPECT imaging.

Authors:  D R Gilland; B M Tsui; W H McCartney; J R Perry; J Berg
Journal:  J Nucl Med       Date:  1988-05       Impact factor: 10.057

7.  Functional assessment with electrocardiographic gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization.

Authors:  M G Levine; C C McGill; A W Ahlberg; M P White; S Giri; B Shareef; D Waters; G V Heller
Journal:  Am J Cardiol       Date:  1999-01-01       Impact factor: 2.778

8.  Detection of coronary artery disease with myocardial contrast echocardiography: comparison with 99mTc-sestamibi single-photon emission computed tomography.

Authors:  S Kaul; R Senior; H Dittrich; U Raval; R Khattar; A Lahiri
Journal:  Circulation       Date:  1997-08-05       Impact factor: 29.690

9.  Prone versus supine thallium myocardial SPECT: a method to decrease artifactual inferior wall defects.

Authors:  G M Segall; M J Davis
Journal:  J Nucl Med       Date:  1989-04       Impact factor: 10.057

10.  Automated quality control for segmentation of myocardial perfusion SPECT.

Authors:  Yuan Xu; Paul Kavanagh; Mathews Fish; James Gerlach; Amit Ramesh; Mark Lemley; Sean Hayes; Daniel S Berman; Guido Germano; Piotr J Slomka
Journal:  J Nucl Med       Date:  2009-08-18       Impact factor: 10.057

View more
  2 in total

Review 1.  Application of the 4-D XCAT Phantoms in Biomedical Imaging and Beyond.

Authors:  W Paul Segars; B M W Tsui; George S K Fung; Ehsan Samei
Journal:  IEEE Trans Med Imaging       Date:  2017-08-10       Impact factor: 10.048

Review 2.  Virtual clinical trials in medical imaging: a review.

Authors:  Ehsan Abadi; William P Segars; Benjamin M W Tsui; Paul E Kinahan; Nick Bottenus; Alejandro F Frangi; Andrew Maidment; Joseph Lo; Ehsan Samei
Journal:  J Med Imaging (Bellingham)       Date:  2020-04-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.